Not Yet RecruitingNot Applicable

Empiric Pulsed Field Pulmonary Vein Isolation During Atrial Tachycardia Ablation in Adults With Congenital Heart Disease

30 participantsStarted 2025-07-01

Plain-language summary

This is a prospective, single-arm intervention trial whereby we will test the safety and efficacy of performing pulmonary vein isolation (PVI) using pulsed field ablation (PFA) in adult patients with congenital heart disease (CHD) who are presenting for atrial tachycardia (AT) ablation.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adult patients (\>= 18 years of age) with repaired or unrepaired congenital heart disease and a history of sustained (\>30 seconds) AT Exclusion Criteria: * History of sustained AF and/or previous catheter or surgical pulmonary vein isolation.

What they're measuring

Acute pulmonary vein isolation

Timeframe: Acute (immediate intraoperative).

Time to atrial tachycardia or atrial fibrillation recurrence

Timeframe: 12 months

Major adverse event

Timeframe: 1 month

Trial details

NCT IDNCT06969378

SponsorBoston Children's Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-06-30

Contact for this trial

Edward O'Leary, MD

6173557833 toleary87@gmail.com

View on ClinicalTrials.gov More Atrial Fibrillation trials